Joint Working Agreements

Bayer is proud to work in partnership with a range of organisations to deliver projects with a direct and measurable benefit to patient care. The projects with which we are currently or recently involved in are listed below:

 

Bayer reference

BU

Period of Agreement

Partner Organisations and NHS Trusts

Declaration

UKXAR07160200c

General Medicine

This project is due to start in March 2017

Innovation Agency, Academic Health Science Network for the North West Coast

To implement an AF focused Quality Improvement Initiative in GP practices to support them in identifying and managing patients

Click here

UKGNR08160029d

Radiology

This project is due to start in March 2017

Wessex Cancer Network

To understand the level of demand for radiology diagnostic services within the speciality of lung cancer and compare the different pathways adopted by each trust so that best practice can be identified and shared. 

Click here

UKXAR08160233c

General Medicine

This project is due to start in March 2017

Yorkshire and Humber Academic Health Science Network

To implement an AF focused Quality Improvement initiative in GP practices to help them in identifying, reviewing and managing patients which will lead to implementing and sustaining changes

Click here

UKXAR07160180c

General Medicine

This project is due to start in January 2017

Oxford Academic Health Science Network

To implement a pharmacist led data review with the aim of improving the management of atrial fibrillation patients across Buckinghamshire and Berkshire.

Click here

UKEYL06160049(1)

Specialty Medicine

This project is due to start in January 2017

Kingston Hospital NHS Foundation Trust

To develop the infrastructure and environment within the Ophthalmology department to remove bottle necks in the service and improve patient throughput.

Click here

UKEYL05160011c

Specialty Medicine

This project is due to start in December 2016

NHS Lothian

To implement a nurse led service that will provide the necessary capacity to allow the Unit to meet the best practice guidance standard.

Click here

UKEYL10160169c

Specialty Medicine

This project is due to start in November 2016

University Hospital Southampton NHS Foundation Trust

The implementation of a mobile eye unit which will increase the capacity of the Eye Unit to meet current and future demand, and allow patients to receive their treatment closer to home.

Click here

UKXAR07160186a

General Medicine

This project is due to start in September 2016

Chelsea & Westminster NHS Foundation Trust

To identify patients who may be unaware that they have atrial fibrillation and ensuring onward referral to an appropriate healthcare professional and improve patient information.

Click here

UKEYL06160049b

Specialty Medicine

This project is due to start in September 2016

Leeds Teaching Hospitals NHS Trust

To introduce virtual clinics for patients with diabetic retinopathy in Leeds, improving the patient pathway and increasing capacity to follow up and treat patients with a range of retinal diseases.

Click here

L.GB.MKT.10.2015.13384b

General Medicine

The project is due to start in January 2016 and run for a period of 12 months.

This is a Joint Working project between Bayer and the Healthbridge Direct GP federation.

The aims and objectives of the project are as follows:
To improve rates of anticoagulation in patients, and to increase the quality of service for patients requiring anticoagulation with AF. Specific aims are broken down here:

  • Patient- Improvement in patient experience. Reduction in waiting times for anticoagulation
  • NHS/HBD- Centralised system to allow management of anticoagulated patients, and development of expert practitioners
  • Bayer- Increase in uptake of Novel Oral Anticoagulants.

Click here

LGB.MKT.09.2015.12825a

General Medicine

The Project will start in September 2015 and finish by June 2016.

Bayer and the West of England AHSN are working in partnership under a Joint Working agreement to facilitate the implementation of phase 2 of the "Don’t wait to anticoagulate" campaign.

We are working to test two different options of supporting practices in Gloucester CCG to ensure that patients at risk of stroke from atrial fibrillation are appropriately anticoagulated. This will then inform the progression to phase 3 in 2016 which could cover the remaining CCGs covered by the WE AHSN

Click here

LGB.NPM.05.2015.11338d

General Medicine

The Project will start on a date to be agreed in July 2015 and finish six months later in December 2015.

Implementing NICE Clinical Guideline on Atrial Fibrillation (CG180) across Oldham CCG using the Rapid Adoption Innovation Framework (RAIF)

Click here

L.GB.10.2014.8296d

General Medicine

20 November 2014 - 19 November 2015

Leeds Teaching Hospitals NHS Trust, Bayer plc, Boehringer Ingelheim Ltd and BMS Pfizer Alliance

Click here

L.GB.12.2014.9008a

General Medicine

Running until end August 2015

Bayer and the West of England AHSN are working in partnership under a Joint Working agreement to facilitate the implementation of the “Don’t wait to anticoagulate” campaign.

We are working to test five different options to upskill the staff in 12 innovator practices across the west of England to improve their management of anticoagulation for patients with Atrial Fibrillation. The findings can then be applied to a CCG wide project in 2015 covering 50+ practices.

Click here

L.GB.01.2014.5049

Women's Health

April 2014 - March 2015

NHS England, London & MSD & Bayer plc

The ‘Improving Choices in Contraception through Training Project’ is designed to improve access & choice of long acting reversible contraception (LARC) to help reduce unintended pregnancy in London. It is a joint working agreement between NHS England, London, and the pharmaceutical companies Bayer Plc and Merck Sharp & Dohme Ltd. The project will deliver LARC training, to nationally recognised standards, to improve the quality of contraception consultations with women, greater access to choice of contraception & increased uptake of LARC

UK.PH.WH.WH2010.274

 

 

 

 

Contract extension: UK.PH.GM.X.2012.045

 

Women's Health

 

 

 

 

General Medicine

 

 

April 2010 - March 2011

 

 

 

 

March 2011 - March 2012

 

 

The London Sexual Health Programme AND Schering-Plough Limited (a part of MSD) AND Bayer plc Bayer Schering Pharma

 

 

 

The London Sexual Health Programme AND Merck Sharp & Dohme Limited (MSD) AND Bayer Plc

 

 

Improving Choices in Contraception through Training: Bayer Schering Pharma has entered into a Joint Working Project with Schering Plough Limited and The London Sexual Health Programme (NHS organisation). The aim of the project is to increase uptake in long term contraceptive use by increasing the number of healthcare professionals trained to fit Long-Acting Reversible Contraceptives (LARC).

 

 

 

 

 

 

 

 

UK.PH.WH.WH2011.81c

Women's Health

November 2009 - November 2010

NHS East of England; Schering-Plough Ltd; Bayer Ltd and Navigate Health (a healthcare management consultancy)

Improving choices in contraception through LARC fitter training provision: Bayer HealthCare has entered into an agreement with East of England Strategic Health Authority, Schering Plough and Navigate Health. The aim of the project is to increase uptake in long-term contraceptive use, in line with NICE guidance. This will be achieved by increasing the number of healthcare professionals trained to fit Long-Acting Reverisble Contraceptives within each Primary Care Trust within this SHA.

UK.PH.WH.WH2011.85c

Women's Health

February 2010 - February 2011

Surrey Primary Care Trust and Bayer plc

Improving choices in contraception through LARC fitter training provision: Bayer HealthCare has entered into an agreement with Surrey Primary Care Trust. The aim of the project is to increase uptake in long-term contraceptive use within Surrey, in line with NICE guidance by increasing the number of healthcare professionals trained to fit Long-Acting Reversible Contraceptives.

UK.PH.WH.WH.2011.445d

 

 

 

 

 

Contract Extension:  L.GB.12.2012.1347

Women's Health

 

 

 

 

 

 

General Medicine - Women's Health

 

December 2011 - December 2012

 

 

 

 

1 December 2012 - 31 March 2013

 

NHS South of Tyne and Wear and Bayer

 

 

 

 

 

NHS South of Tyne and Wear and Bayer

 

Improving choices in contraception through LARC (long acting and reversible contraception) training provision: Bayer Healthcare has entered into a Joint Working project with NHS South of Tyne and Wear (Sunderland, South Tyneside and Gateshead PCTs) (NHS organisation). The aim of the project is to increase patient choice in contraception and uptake of long-term contraceptives within South of Tyne and Wear, in line with NICE guidance, by increasing the capacity for training Healthcare professionals to fit Long-Acting Reversible Contraceptives.

 

 

 

UK.PH.WH.WH.2011.499d

Women's Health

Dec 2011 - May 2012

South West Strategic Health Authority ("NHS South West") AND Organon Laboratories Limited ("MSD") AND Bayer PLC ("Bayer")

NHS South West, MSD and Bayer are working in partnership for a second year to achieve region-wide implementation of NICE LARC Guidance, October 2005.  This collaborative project aims to support an impact on region-wide teenage pregnancy rates, unintended pregnancy rates and abortion rates.  This executive summary provides information that outlines NHS South West, MSD and Bayer as the key partners involved in the project, highlights the key objectives of the project outlined below and, describes the process to achieve region-wide implementation of LARC which comprises activity that aims; 

  • To increase access to the full range of contraceptive options which include LARC, in conjunction with increasing general knowledge and awareness of the options available to women across healthcare professionals and the public
  • To increase access to training and education for healthcare professionals to support increased LARC provision across specialist contraceptive services and general practice.
  • To support areas of highest need to help impact on a reduction in health inequalities.   

This collaborative arrangement is active from    
December 2011 - May 2012.
 

UK.PH.WH.WH.2011.446d

Women's Health

January 2012 - December 2012

NHS Teesside and Bayer

Improving choices in contraception through LARC (long acting and reversible contraception)  training provision:  Bayer Healthcare has entered into a Joint Working project with Tees Training Programme (covering Redcar & Cleveland, Middlesbrough, North Tees and Hartlepool PCTs)  (NHS organisation).  The aim of the project is to increase patient choice in contraception and uptake of long-term contraceptives within Teesside, in line with NICE guidance, by increasing the capacity for training Healthcare professionals to fit Long-Acting Reversible Contraceptives.